Literature DB >> 33905478

Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic.

Liise-Anne Pirofski1.   

Abstract

Year:  2021        PMID： 33905478     DOI： 10.1093/cid/ciab374

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination.

Authors:  Li Tang; Sean Cherry; Elaine I Tuomanen; Ericka Kirkpatrick Roubidoux; Chun Yang Lin; Kim J Allison; Ashleigh Gowen; Pamela Freiden; E Kaitlynn Allen; Yin Su; Aditya H Gaur; Jeremie H Estepp; Maureen A McGargill; Florian Krammer; Paul G Thomas; Stacey Schultz-Cherry; Joshua Wolf
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations.

Authors:  Caiqin Hu; Dan Li; Zhanmou Liu; Li Ren; Junwei Su; Meiling Zhu; Yi Feng; Zheng Wang; Qiang Liu; Biao Zhu; Yiming Shao
Journal:  Pathogens       Date:  2022-01-27

3.  A Rapid and Sensitive Microfluidics-Based Tool for Seroprevalence Immunity Assessment of COVID-19 and Vaccination-Induced Humoral Antibody Response at the Point of Care.

Authors:  Kritika Srinivasan Rajsri; Michael P McRae; Glennon W Simmons; Nicolaos J Christodoulides; Hanover Matz; Helen Dooley; Akiko Koide; Shohei Koide; John T McDevitt
Journal:  Biosensors (Basel)       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.